bisoprolol has been researched along with perindopril in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (35.48) | 29.6817 |
| 2010's | 10 (32.26) | 24.3611 |
| 2020's | 10 (32.26) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Egashira, K; Ito, A; Muramatsu, K; Narishige, T; Takeshita, A | 1 |
| Girerd, X | 1 |
| Ito, T; Minami, S; Miyazaki, H; Mochizuki, S; Okazaki, F; Onodera, T; Seki, S; Taniguchi, I; Taniguchi, M | 1 |
| Chen, XJ; Fang, WW; Geng, Q; Wu, XH; Yang, D; Zhang, JN | 1 |
| Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG | 1 |
| Czupryniak, L; Loba, J; Pawłowski, M; Saryusz-Wolska, M | 1 |
| Berlion, AE; Morkel, H; Smedema, JP | 1 |
| Remme, WJ | 1 |
| Linnik, SA; Naurbieva, EN; Ponomareva, EP | 1 |
| Basiak, M; Buldak, L; Dulawa, A; Madej, A; Okopien, B; Szkrobka, W | 1 |
| Chow, K; Ezekowitz, J; Haykowsky, M; Koshman, S; Mackey, JR; Oudit, G; Pagano, JJ; Paterson, I; Pituskin, E; Thompson, RB | 1 |
| Dubuisson, N; Dupuis, F; Dupuis, M; Evrard, F; van Rijckevorsel, K; Van Robays, P | 1 |
| Basiak, M; Bołdys, A; Bułdak, L; Labuzek, K; Madej, A; Okopień, B | 1 |
| Das, M | 1 |
| Canivet, A; Falque, B; Gach, O; Krzesinski, F; Krzesinski, JM; Lancellotti, P | 1 |
| Murphy, G; Murphy, JEJ; O'Gorman, SM; Powers, JM; Ralph, N | 1 |
| Dąbek, J; Madej, A; Majewski, M; Szuta, J | 1 |
| Gilyarevsky, SR; Golshmid, MV; Kuzmina, IM | 1 |
| Abbas, SS; Elghobashy, MR; Hassan, SA; Moustafa, AA; Nashat, NW | 2 |
| Boytsov, SA; Burtsev, YP; Karpov, YA; Khomitskaya, YV | 1 |
| Abbas, SS; Eid, SM; Elghobashy, MR; Hassan, SA; Moustafa, AA; Nashat, NW | 1 |
| Abeel, M; Constance, C; Gupta, A | 1 |
| Gavrilova, A; Latkovskis, G; Urtāne, I; Zolovs, M | 1 |
| Burtsev, Y; Kobalava, Z; Kvasnikov, B | 1 |
| Almalki, MA; Binsaleh, AY; Mahmoud, OA; Mohamed, MA; Omran, AA | 1 |
| Tchernev, G | 2 |
4 review(s) available for bisoprolol and perindopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Defibrillators, Implantable; Disease Progression; Enalapril; Heart Failure; Humans; Perindopril; Propanolamines; Treatment Outcome; Ventricular Remodeling | 2007 |
Takotsubo syndrome (TKS): a possible mechanism of sudden unexplained death in epilepsy (SUDEP).
Topics: Adrenergic beta-1 Receptor Antagonists; Anticonvulsants; Aspirin; Bisoprolol; Death, Sudden; Epilepsy; Female; Fibrinolytic Agents; Humans; Lamotrigine; Middle Aged; Perindopril; Takotsubo Cardiomyopathy; Triazines; Valproic Acid | 2012 |
[Bipressil® : first single-pill combination of bisoprolol and perindopril arginine].
Topics: Antihypertensive Agents; Bisoprolol; Drug Combinations; Humans; Perindopril | 2017 |
5 trial(s) available for bisoprolol and perindopril
| Article | Year |
|---|---|
Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Bisoprolol; Blood Pressure; Endothelium, Vascular; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Nitric Oxide Synthase; Perindopril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; von Willebrand Factor | 2001 |
Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Indapamide; Indoles; Male; Middle Aged; Nitrendipine; Perindopril; Spironolactone | 2007 |
[Effect of the angiotensin converting enzyme inhibitor, perindopril, on heart rhythm variability and adrenoreactivity in patients with ischemic heart disease associated with duodenal ulcer].
Topics: Adrenal Glands; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Duodenal Ulcer; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Perindopril; Treatment Outcome | 2007 |
The effects of 1 month antihypertensive treatment with perindopril, bisoprolol or both on the ex vivo ability of monocytes to secrete inflammatory cytokines.
Topics: Adult; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Case-Control Studies; Chemokine CCL2; Drug Therapy, Combination; Female; Humans; Hypertension; Interleukins; Male; Middle Aged; Monocytes; Perindopril; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2009 |
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzu
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Humanized; Apoptosis; Bisoprolol; Breast Neoplasms; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Perindopril; Placebos; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Research Design; Trastuzumab; Ventricular Remodeling | 2011 |
22 other study(ies) available for bisoprolol and perindopril
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Management of essential arterial hypertension].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Diuretics; Drug Therapy, Combination; France; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Middle Aged; Patient Selection; Perindopril; Practice Guidelines as Topic; Prognosis; Risk Factors; Societies, Medical; Sodium Chloride Symporter Inhibitors; Time Factors; World Health Organization | 2000 |
Perindopril reverses myocyte remodeling in the hypertensive heart.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bisoprolol; Cell Count; Cell Size; Dose-Response Relationship, Drug; Echocardiography; Female; Heart; Hypertension; Myocardium; Perindopril; Rats; Rats, Inbred SHR; Ventricular Remodeling | 2002 |
Alteration of endothelin system and calcium handling protein in left ventricles following drug treatment in dilated cardiomyopathy rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bisoprolol; Calcium Channels; Calcium-Transporting ATPases; Cardiomyopathy, Dilated; Heart Ventricles; Inositol 1,4,5-Trisphosphate Receptors; Male; Myocardium; Perindopril; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Receptors, Cytoplasmic and Nuclear; Receptors, Endothelin; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2003 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Baroreflex; Bisoprolol; Carbazoles; Carvedilol; Data Interpretation, Statistical; Death, Sudden, Cardiac; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Perindopril; Phenylephrine; Propanolamines; Time Factors; Ventricular Dysfunction, Left | 2004 |
Myocardial infarcts in a patient with a single right sided coronary ostium and interarterial course of the circumflex artery: the role of multi-modality imaging.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Bisoprolol; Coronary Angiography; Coronary Vessel Anomalies; Coronary Vessels; Female; Humans; Magnetic Resonance Angiography; Middle Aged; Myocardial Infarction; Perindopril; Platelet Aggregation Inhibitors; Simvastatin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2009 |
Short-term antihypertensive therapy lowers the C-reactive protein level.
Topics: Adult; Antihypertensive Agents; Biomarkers; Bisoprolol; Blood Pressure; C-Reactive Protein; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril | 2012 |
Small benefits in trastuzumab-related cardiotoxicity.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents, Immunological; Bisoprolol; Breast Neoplasms; Cardiotoxicity; Female; Humans; Perindopril; Randomized Controlled Trials as Topic; Stroke Volume; Time Factors; Trastuzumab; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Polypharmacy and sun exposure: Implications for mitochondrial DNA deletions in skin.
Topics: Aged; Allopurinol; Atorvastatin; Bisoprolol; Cholesterol; DNA Damage; DNA, Mitochondrial; Gene Deletion; Humans; Mitochondria; Perindopril; Pravastatin; Real-Time Polymerase Chain Reaction; Skin; Ubiquinone; Ultraviolet Rays | 2017 |
Effect of perindopril and bisoprolol on IL-2, INF-γ, hs-CRP and T-cell stimulation and correlations with blood pressure in mild and moderate hypertension.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterial Pressure; Biomarkers; Bisoprolol; C-Reactive Protein; Case-Control Studies; Female; Humans; Hypertension; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Male; Middle Aged; Perindopril; Severity of Illness Index; T-Lymphocytes; Time Factors; Treatment Outcome | 2018 |
Topics: Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Drug Therapy, Combination; Humans; Hypertension; Myocardial Ischemia; Perindopril | 2018 |
Stability-Indicating RP-HPLC and CE Methods for Simultaneous Determination of Bisoprolol and Perindopril in Pharmaceutical Formulation: A Comparative Study.
Topics: Bisoprolol; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Contamination; Drug Stability; Electrophoresis, Capillary; Limit of Detection; Linear Models; Perindopril; Reproducibility of Results; Tablets | 2020 |
Effectiveness and Tolerability of the Single-Pill Combination of Bisoprolol and Perindopril in Patients with Arterial Hypertension and Stable Coronary Artery Disease in Daily Clinical Practice: The STYLE Study.
Topics: Aged; Antihypertensive Agents; Bisoprolol; Blood Pressure; Coronary Artery Disease; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Russia; Treatment Outcome | 2021 |
Optimization of localized surface plasmon resonance hot spots in surface-enhanced infrared absorption spectroscopy aluminum substrate as an optical sensor coupled to chemometric tools for the purity assay of quinary mixtures.
Topics: Aluminum; Bisoprolol; Citric Acid; Drug Contamination; Indoles; Limit of Detection; Metal Nanoparticles; Perindopril; Silver; Spectrophotometry, Infrared; Surface Plasmon Resonance; Tablets | 2021 |
Concomitant Treatment of Hypertensive Patients with Bisoprolol and Perindopril in Routine Clinical Practice: A Post Hoc Analysis of the CONFIDENCE II, PROTECT I, and PROTECT III Observational Studies.
Topics: Aged; Antihypertensive Agents; Bisoprolol; Blood Pressure; Canada; Drug Combinations; Humans; Hypertension; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2022 |
Advanced chemometric methods as powerful tools for impurity profiling of drug substances and drug products: Application on bisoprolol and perindopril binary mixture.
Topics: Bisoprolol; Chemometrics; Least-Squares Analysis; Perindopril; Pharmaceutical Preparations | 2022 |
The Impact of International Nonproprietary Names Integration on Prescribing Reimbursement Medicines for Arterial Hypertension and Analysis of Medication Errors in Latvia.
Topics: Bisoprolol; Humans; Hypertension; Latvia; Medication Errors; Perindopril; Retrospective Studies | 2022 |
Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study.
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Bisoprolol; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Perindopril; Retrospective Studies; Treatment Outcome | 2023 |
Chromatographic Techniques for Assessment of Bisoprolol Fumarate and Perindopril Arginine in Solid Formulations under Various Stress Conditions and Application to Six Sigma, Content Uniformity, and Comparative Dissolution Approaches.
Topics: Arginine; Bisoprolol; Perindopril; Solubility; Total Quality Management | 2023 |
THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Felodipine; Humans; Lisinopril; Melanoma; Metoprolol; Nitrosamines; Perindopril; Prospective Studies; Skin Neoplasms; Sodium Chloride Symporter Inhibitors; Thiazides | 2023 |
NITROSOGENESIS OF SKIN CANCER: THE NITROSAMINE CONTAMINATION IN THE CALCIUM CHANNEL BLOCKERS (AMLODIPINE), BETA BLOCKERS (BISOPROLOL), SARTANS (VALSARTAN/LOSARTAN), ACE INHIBITORS (PERINDOPRIL/ENALAPRIL), TRICYCLIC ANTIDEPRESSANTS (MELITRACEN), SSRIS (PAR
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Tricyclic; Bisoprolol; Calcium Channel Blockers; Enalapril; Humans; Incidence; Losartan; Metformin; Paroxetine; Perindopril; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Skin Neoplasms; Valsartan; Venlafaxine Hydrochloride | 2023 |